Communicable Diseases Act, B.E. 2558 (2015) · communicable disease under surveillance

Notification of the Ministry of Public Health Re: The names and presenting symptoms of communicable diseases under surveillance, (No.3), B.E. 2565 (2022)

Published in the Government Gazette 20 September B.E. 2565 (2022); in force from 1 October B.E. 2565 (2022)

Whereas it is expedient to announce Coronavirus Disease 2019 or COVID-19 as a communicable disease under surveillance pursuant to the Communicable Diseases Act, B.E. 2558 (2015), for the purposes of surveillance, prevention and control of the communicable disease.

By virtue of section 5 and section 6 (1) of the Communicable Diseases Act, B.E. 2558 (2015), the Minister of Public Health by and with the advice of the National Communicable Disease Committee, hereby issues the following Notification:

Clause 1. This Notification is called “Notification of the Ministry of Public Health Re: the names and presenting symptoms of communicable diseases under surveillance (No.3), B.E. 2565 (2022).

Clause 2. This Notification shall come into force from 1st Day of October B.E. 2565 (2022) onwards.

Clause 3. The following provision shall be added as item 57 of clause 4 of the Notification of the Ministry of Public Health Re: the names and presenting symptoms of communicable diseases under surveillance, B.E. 2562 (2019)

“(57) Coronavirus Disease 2019 or COVID-19 is characterized by a fever, cough, sore throat, dyspnea, or symptoms of pneumonia; in severe cases, respiratory failure may occur, which could lead to death.”

Announced on 19th Day of September B.E. 2565 (2022)

Anutin Charnvirakul

Minister of Public Health

Unofficial English translation by the Division of Legal Affairs, Department of Disease Control (August 2025), book page 73; the Thai text prevails.